Cytomorphological variations, proliferation and angiogenesis in the prognosis of cutaneous melanoma

Clinical and Experimental Dermatology

Volumn 28, Issue 3, 2003, Pages 310-314

  Jonjic, N ^a   Zamolo, G ^a   Stifter S ^a   Fuckar, D ^a   Gruber, F ^b   Sasso, F ^c   Rizzardi, C ^c   Melato, M ^c  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b KBC RIJEKA   (Croatia)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ANGIOGENESIS; ARTICLE; BRESLOW THICKNESS; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; CLARK LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA; MITOSIS RATE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION;

HUMANS; MELANOMA; MITOTIC INDEX; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037777871     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01270.x     Document Type: Article

References (23)

1. Banerjee SS. Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000; 36: 387-402.
2. Blum A, Brand CU, Ellwanger U et al. Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol 1999; 141: 783-7.
3. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
4. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147: 9-19.
5. Mackie RH, Clark DH. Cochran AJ. Melanoma in the West of Scotland 1939-1981. In: Cutaneous Melanoma (Balch CM, Milton GW, eds). Philadelphia: J. B. Lippincott Company, 1985: 480.
6. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
7. Kawahira K. Immunohistochemical staining of proliferating nuclear antigen (PCNA) in malignant and non-malignant skin diseases. Arch Dermatol Res 1999; 291: 413-8.
8. Kuwata T, Kitagawa M, Kasuga T. Proliferative activity of primary cutaneous melanocytic tumours. Virchow Arch 1993; 423: 359-64.
9. Tokuda Y, Mukai K, Matsuno Y et al. Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index. Arch Dermatol Res 1992; 284: 319-23.
10. McNutt NS, Urmacher C, Hakimian J et al. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity. J Cutan Pathol 1995; 22: 502-17.
11. Moniem H, Choi YJ, Niedt W. Expression of Ki-67, PCNA, p53, and HMB-45 in melanocytic lesions. J Tumor Marker Oncol 1999; 14: 11-7.
12. Girod SC, Groth W, Junk M, Gerlach KL. p53 and PCNA expression in malignant melanomas of the head and neck. Pigment Cell Res 1994; 7: 354-7.
13. Bjornhagen V, Bonfoco E, Brahme EM et al. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma. Am J Dermatopathol 1994; 16: 615-23.
14. Karjalainen JM, Eskelinen MJ, Kellokoski JK et al. p21 (WAF1/CIP!) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival. Br J Cancer 1999; 79: 895-902.
15. Woosley JT, Dietrich DR. Prognostic significance of PCNA grade in malignant melanoma. J Cutan Pathol 1993; 20: 498-503.
16. Roels S, Tilmant K, Ducatelle R. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs. J Comp Pathol 1999; 121: 13-24.
17. Ghazvini S, Kroll S, Char DH, Frigillan H. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma. Invest Ophthalmol Vis Sci 1995; 36: 2762-7.
18. Evans AT, Blessing K, Orrell JM, Grant A. Mitotic indices, anti-PCNA immunostaining, and AgNORs in thick cutaneous melanomas displaying paradoxical behaviour. J Pathol 1992; 168: 15-22.
19. Karjalainen JM, Eskelinen MJ, Nordling S et al. Mitotic rate and s-phase fraction as prognostic factors in stage I cutaneous malignant melanoma. Br J Cancer 1998; 77: 1917-25.
20. Marcaval J, Moreno A, Graells J et al. Angiogenesis and malignant melanoma. J Cutan Pathol 1997; 24: 212-8.
21. De Waal RMW, Van Altena MC, Erhard H et al. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. Am J Pathol 1999; 150: 1951-7.
22. Straume O, Salvesen HB, Akslen LA. Angiogenesis is important in vertical growth phase melanomas. Intern J Oncol 1999; 15: 595-9.
23. Belien JAM, Van Diest PJ, Baak JPA. Relationships between vascularization and proliferation in invasive breast cancer. J Pathol 1999; 189: 309-18.